Moderate continuous training group for Colorectal Cancer

Phase-Based Progress Estimates
Colorectal Cancer+2 MoreModerate continuous exercise - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial will test whether exercising before surgery can improve outcomes. Patients will be assigned to different exercise regimens, with all participants wearing an Apple watch to track activity.

Eligible Conditions
  • Colorectal Cancer
  • Liver Cancer
  • Gynecologic Cancers

Treatment Effectiveness

Study Objectives

0 Primary · 13 Secondary · Reporting Duration: During participant accrual, estimated to take about 12 months

30 days after surgery
Surgical complications
Day 1
Health-related quality of life
Pain intensity
Pain interference
Physical activity level by self report
Day 180
Fitness level
Month 12
Enrollment rate
Day 1
Compliance with EXi smartphone application
Compliance with exercise intervention, including percentage of exercise goals reached
Day 30
Steps per day
Day 30
Completion/Dropout rate
Percentage of time wearing Apple Watch
Day 30
Length of hospital stay (in days) following surgery

Trial Safety

Trial Design

3 Treatment Groups

Moderate continuous training group
1 of 3
Control group
1 of 3
High intensity interval training group
1 of 3

Active Control

57 Total Participants · 3 Treatment Groups

Primary Treatment: Moderate continuous training group · No Placebo Group · N/A

Moderate continuous training group
ActiveComparator Group · 1 Intervention: Moderate continuous exercise · Intervention Types: Behavioral
Control groupNoIntervention Group · 1 Intervention: Control group · Intervention Types:
High intensity interval training group
ActiveComparator Group · 1 Intervention: High intensity interval exercise · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: during participant accrual, estimated to take about 12 months

Who is running the clinical trial?

University of VirginiaLead Sponsor
685 Previous Clinical Trials
1,426,991 Total Patients Enrolled
Traci Hedrick, MDPrincipal InvestigatorUVA
2 Previous Clinical Trials
35 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must be able to understand written and verbal English, and to be able to communicate in English.
You must be able to provide written informed consent and authorization.
You must have an iPhone to use during the study period.